Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
23 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Acumen Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Acumen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Acumen Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Acumen Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Acumen Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Acumen Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Acumen Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Acumen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acumen Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Acumen Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Acumen Pharmaceuticals, Inc. Snapshot 4 Acumen Pharmaceuticals, Inc. Overview 4 Key Information 4 Key Facts 4 Acumen Pharmaceuticals, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Acumen Pharmaceuticals, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Acumen Pharmaceuticals, Inc. - Pipeline Products Glance 9 Acumen Pharmaceuticals, Inc. - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Acumen Pharmaceuticals, Inc. - Drug Profiles 10 ACU-193 10 Product Description 10 Mechanism of Action 10 R&D Progress 10 ACU-193 Back-up 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Drugs to Inhibit ADDL Receptor for Alzheimers Disease 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Vaccine to Target ADDL for Alzheimers Disease 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Acumen Pharmaceuticals, Inc. - Pipeline Analysis 16 Acumen Pharmaceuticals, Inc. - Pipeline Products by Target 16 Acumen Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 17 Acumen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 18 Acumen Pharmaceuticals, Inc. - Recent Pipeline Updates 19 Acumen Pharmaceuticals, Inc. - Dormant Projects 20 Acumen Pharmaceuticals, Inc. - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 23 Disclaimer 23
List of Tables Acumen Pharmaceuticals, Inc., Key Information 4 Acumen Pharmaceuticals, Inc., Key Facts 4 Acumen Pharmaceuticals, Inc. - Pipeline by Indication, 2014 6 Acumen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 7 Acumen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 8 Acumen Pharmaceuticals, Inc. - Preclinical, 2014 9 Acumen Pharmaceuticals, Inc. - Pipeline by Target, 2014 16 Acumen Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 17 Acumen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 18 Acumen Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 19 Acumen Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 20
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.